Gland Pharma Ltd. | Large-cap | Real Estate
₹1,764.90
1.18%
| Gland Pharma Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 56.4B
Gross Profit 34.7B 61.48%
Operating Income 10.0B 17.66%
Net Income 7.7B 13.69%
EPS (Diluted) ₹46.89

Balance Sheet Metrics

Total Assets 112.2B
Total Liabilities 20.7B
Shareholders Equity 91.5B
Debt to Equity 0.23

Cash Flow Metrics

Operating Cash Flow 7.5B
Free Cash Flow 5.2B

Revenue & Profitability Trend

Gland Pharma Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 56.4B 35.9B 43.8B 34.2B 25.7B
Cost of Goods Sold 21.7B 16.9B 21.1B 14.9B 11.0B
Gross Profit 34.7B 19.1B 22.7B 19.3B 14.7B
Operating Expenses 8.8B 5.0B 4.4B 3.6B 3.0B
Operating Income 10.0B 8.9B 14.0B 12.0B 8.6B
Pre-tax Income 11.3B 10.5B 16.2B 13.3B 9.9B
Income Tax 3.6B 2.7B 4.1B 3.4B 2.2B
Net Income 7.7B 7.8B 12.1B 10.0B 7.7B
EPS (Diluted) ₹46.89 ₹47.43 ₹73.64 ₹62.99 ₹47.33

Income Statement Trend

Gland Pharma Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 67.8B 56.5B 69.0B 58.5B 51.2B
Non-Current Assets 44.4B 50.2B 18.8B 19.8B 13.7B
Total Assets 112.2B 106.6B 87.8B 78.3B 65.0B
Liabilities
Current Liabilities 15.6B 14.0B 7.3B 5.8B 5.1B
Non-Current Liabilities 5.1B 5.4B 896.8M 939.8M 803.1M
Total Liabilities 20.7B 19.4B 8.2B 6.8B 5.9B
Equity
Total Shareholders Equity 91.5B 87.2B 79.6B 71.6B 59.0B

Balance Sheet Composition

Gland Pharma Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 10.6B 11.3B 10.5B 16.2B 13.3B
Operating Cash Flow 7.5B 13.4B 3.9B 10.2B 6.9B
Investing Activities
Capital Expenditures -3.8B -3.9B -2.2B -5.1B -2.3B
Investing Cash Flow 15.6B -18.9B 10.5B -11.2B -15.9B
Financing Activities
Dividends Paid -3.3B - - - -
Financing Cash Flow -3.8B -7.6B 213.8M 384.2M 12.4B
Free Cash Flow 5.2B 6.0B 1.4B 2.7B 3.8B

Cash Flow Trend

Gland Pharma Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 40.65
Forward P/E 26.51
Price to Book 3.10
Price to Sales 5.06
PEG Ratio 26.51

Profitability Ratios

Profit Margin 12.44%
Operating Margin 17.67%
Return on Equity 7.82%
Return on Assets 5.09%

Financial Health

Current Ratio 4.34
Debt to Equity 3.43
Beta 0.32

Per Share Data

EPS (TTM) ₹42.40
Book Value per Share ₹555.30
Revenue per Share ₹340.92

Financial data is updated regularly. All figures are in the company's reporting currency.